Abstract

Background. Cardiogenic shock (CS) is the leading cause of in-hospital mortality in ST-segment elevation myocardial infarction (STEMI). Only limited data are available on the long-term outcome of STEMI patients with CS undergoing contemporary treatment. We aimed to investigate long-term mortality and its predictors in STEMI patients with CS and to develop a risk score for long-term mortality prediction. Methods and Results. We retrospectively included 465 patients with STEMI complicated by CS and treated with primary angioplasty and intra-aortic balloon pump between 2005 and 2018. Long-term mortality, including both in-hospital mortality and all-cause mortality following discharge from the index hospitalization, was the primary endpoint. The long-term mortality (median follow-up 4 (2.0–5.2) years) was 60%, including in-hospital mortality (34%). At multivariate analysis, independent predictors of long-term mortality were age (HR 1.41, each 10-year increase), admission left ventricular ejection fraction (HR 1.51, each 10%-unit decrease) and creatinine (HR 1.28, each mg/dl increase), and acute kidney injury (HR 1.81). When these predictors were pooled together, the area under the curve (AUC) for long-term mortality was 0.80 (95% CI 0.75–0.84). Using the four variables, we developed a risk score with a mean (cross-validation analysis) AUC of 0.79. When the score was applied to in-hospital mortality, its AUC was 0.79, and 0.76 when the score was applied to all-cause mortality following discharge. Conclusions. In STEMI patients with CS, the risk of death is still substantial in the years following the index event. A simple clinical score at the time of the index event accurately predicts long-term mortality risk.

Highlights

  • Cardiogenic shock (CS) is the leading cause of in-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI)

  • We investigated very long-term mortality, including in-hospital mortality, in a real-world population of consecutive patients with STsegment elevation myocardial infarction (STEMI) complicated by CS at hospital admission who were treated with primary percutaneous coronary intervention (pPCI) and intra-aortic balloon pump (IABP)

  • The data analyzed in this retrospective study were obtained from consecutive patients with STEMI complicated by CS at hospital admission who were treated with pPCI and IABP at the Centro Cardiologico Monzino in Milan, Italy, between 1 January 2005 and 1 January 2018, and the Policlinico San Matteo of Pavia, Italy, between 1 January 2005 and 25 September 2017

Read more

Summary

Introduction

Cardiogenic shock (CS) is the leading cause of in-hospital mortality in patients with ST-segment elevation myocardial infarction (STEMI). The usual treatment is primary percutaneous coronary intervention (pPCI) and peri-procedural circulatory support with an intra-aortic balloon pump (IABP) [4,5] Despite this therapeutic approach, early mortality of these patients is still high, ranging from 30% to 50% [4,5,6,7,8,9,10]. When studies focusing only on patients with acute myocardial infarction and CS are considered, a very high long-term mortality rate—up to almost 70% at six years—has been reported in large randomized trials [15,16] This suggests that the risk of death is still substantial even after the acute phase. A simple clinical score at the time of the index event accurately predicts long-term mortality risk

Objectives
Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.